The Ten Most Promising Net Cash Stocks [View article]
ATHX / NEW SEC FILINGS / INSIDERS ARE BUYING NOW March 2009. Just Announced . finance.yahoo.com/q/it...
INSIDER TRANSACTIONS REPORTED - LAST TWO YEARS Date Insider Shares Type Transaction Value* 17-Mar-09 SHEFFERY MICHAEL BDirector 110,000 Indirect Purchase at $0.84 per share. $92,400 17-Mar-09 ORBIMED ADVISORS LLCDirector 110,000 Indirect Purchase at $0.84 per share. $92,400 16-Mar-09 SHEFFERY MICHAEL BDirector 52,200 Indirect Purchase at $0.65 per share. $33,930 16-Mar-09 ORBIMED ADVISORS LLCDirector 52,200 Indirect Purchase at $0.65 per share. $33,930 16-Mar-09 VAN BOKKELEN GILOfficer 10,000 Direct Purchase at $0.67 per share. $6,700
The Ten Most Promising Net Cash Stocks [View article]
ATHX Trades at like 50 Cents on the $1.00 Just on Cash Alone. ZERO DEBT / Book Value About $1.70
ATHX .. $1.50 in Cash per share and trading at .75 Cents. Zero Long term Debt and a huge Stem cell Pipeline.....
How can a stock with a pipeline and $1.50 in cash per every share outstanding and ZERO - 0 Long term Debt, trade at less than their cash.
Trading at .75 Cents. Does this make any sense..
Can some of you , who understand financials .. Explain this to me....
I have a Masters in Finance, and I still dont get it....
Its like buying a $1.00 Bill for .50 Cents , as this is approximately 50% of their cash value.........
Anyone else have a stock trading at 50% Below Cash and 0 Debt...
Cause, I dont see too many of these come around. Especially in the biotech / stem cell sector.....
Comments welcomed.
Balance Sheet Total Cash (mrq): 28.01M Total Cash Per Share (mrq): 1.48 Total Debt (mrq): 0 Total Debt/Equity (mrq): N/A Current Ratio (mrq): 12.577 Book Value Per Share (mrq): 1.668
Share Statistics Average Volume (3 month)3: 157,118 Average Volume (10 day)3: 87,912.5 Shares Outstanding5: 18.93M Float: 12.71M % Held by Insiders1: 23.09% % Held by Institutions1: 29.10%
The Ten Most Promising Net Cash Stocks [View article]
ATHX / NEW SEC FILINGS / INSIDERS ARE BUYING NOW March 2009. Just Announced . finance.yahoo.com/q/it...
INSIDER TRANSACTIONS REPORTED - LAST TWO YEARS Date Insider Shares Type Transaction Value* 17-Mar-09 SHEFFERY MICHAEL BDirector 110,000 Indirect Purchase at $0.84 per share. $92,400 17-Mar-09 ORBIMED ADVISORS LLCDirector 110,000 Indirect Purchase at $0.84 per share. $92,400 16-Mar-09 SHEFFERY MICHAEL BDirector 52,200 Indirect Purchase at $0.65 per share. $33,930 16-Mar-09 ORBIMED ADVISORS LLCDirector 52,200 Indirect Purchase at $0.65 per share. $33,930 16-Mar-09 VAN BOKKELEN GILOfficer 10,000 Direct Purchase at $0.67 per share. $6,700
The Ten Most Promising Net Cash Stocks [View article]
Just Announced .
finance.yahoo.com/q/it...
INSIDER TRANSACTIONS REPORTED - LAST TWO YEARS
Date Insider Shares Type Transaction Value*
17-Mar-09 SHEFFERY MICHAEL BDirector 110,000 Indirect Purchase at $0.84 per share. $92,400
17-Mar-09 ORBIMED ADVISORS LLCDirector 110,000 Indirect Purchase at $0.84 per share. $92,400
16-Mar-09 SHEFFERY MICHAEL BDirector 52,200 Indirect Purchase at $0.65 per share. $33,930
16-Mar-09 ORBIMED ADVISORS LLCDirector 52,200 Indirect Purchase at $0.65 per share. $33,930
16-Mar-09 VAN BOKKELEN GILOfficer 10,000 Direct Purchase at $0.67 per share. $6,700
The Ten Most Promising Net Cash Stocks [View article]
ATHX .. $1.50 in Cash per share and trading at .75 Cents. Zero Long term Debt and a huge Stem cell Pipeline.....
How can a stock with a pipeline and $1.50 in cash per every share outstanding and ZERO - 0 Long term Debt, trade at less than their cash.
Trading at .75 Cents. Does this make any sense..
Can some of you , who understand financials .. Explain this to me....
I have a Masters in Finance, and I still dont get it....
Its like buying a $1.00 Bill for .50 Cents , as this is approximately 50% of their cash value.........
Anyone else have a stock trading at 50% Below Cash and 0 Debt...
Cause, I dont see too many of these come around. Especially in the biotech / stem cell sector.....
Comments welcomed.
Balance Sheet
Total Cash (mrq): 28.01M
Total Cash Per Share (mrq): 1.48
Total Debt (mrq): 0
Total Debt/Equity (mrq): N/A
Current Ratio (mrq): 12.577
Book Value Per Share (mrq): 1.668
Share Statistics
Average Volume (3 month)3: 157,118
Average Volume (10 day)3: 87,912.5
Shares Outstanding5: 18.93M
Float: 12.71M
% Held by Insiders1: 23.09%
% Held by Institutions1: 29.10%
The Ten Most Promising Net Cash Stocks [View article]
Just Announced .
finance.yahoo.com/q/it...
INSIDER TRANSACTIONS REPORTED - LAST TWO YEARS
Date Insider Shares Type Transaction Value*
17-Mar-09 SHEFFERY MICHAEL BDirector 110,000 Indirect Purchase at $0.84 per share. $92,400
17-Mar-09 ORBIMED ADVISORS LLCDirector 110,000 Indirect Purchase at $0.84 per share. $92,400
16-Mar-09 SHEFFERY MICHAEL BDirector 52,200 Indirect Purchase at $0.65 per share. $33,930
16-Mar-09 ORBIMED ADVISORS LLCDirector 52,200 Indirect Purchase at $0.65 per share. $33,930
16-Mar-09 VAN BOKKELEN GILOfficer 10,000 Direct Purchase at $0.67 per share. $6,700